Treatment-related amyloid clearance (TRAC): a framework to characterize patients in the era of anti-amyloid therapies.
Saved in:
| Title: | Treatment-related amyloid clearance (TRAC): a framework to characterize patients in the era of anti-amyloid therapies. |
|---|---|
| Authors: | La Joie R; Edward and Pearl Fein Memory and Aging Center, UCSF Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, California, USA., Cummings JL; Chambers-Grundy Center for Transformative Neuroscience, Department of Brain Health, School of Integrated Health Sciences, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, Nevada, USA., Dage JL; Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA., Galasko D; Department of Neurosciences and Shiley-Marcos Alzheimer's Disease Research Center, University of California, San Diego, California, USA., Ikonomovic MD; Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.; Geriatric Research Education and Clinical Center, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA.; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Karikari TK; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Landau SM; Neuroscience Department, University of California Berkeley, Berkeley, California, USA., Llibre-Guerra JJ; Department of Neurology, Washington University in St Louis, St Louis, Missouri, USA., Mummery CJ; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.; Cognitive Disorders Service, National Hospital for Neurology and Neurosurgery, University College London Hospital NHS Foundation Trust, London, UK., Ossenkoppele R; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Faculty of Medicine, Lund University, Lund, Sweden., Price JC; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Risacher SL; Section of Gerontology and Geriatric Medicine, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.; Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, Indiana, USA., Smith R; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Faculty of Medicine, Lund University, Lund, Sweden., van Dyck CH; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA., Carrillo MC; Medical & Scientific Relations Division, Alzheimer's Association, Chicago, Illinois, USA. |
| Source: | Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2025 Nov; Vol. 21 (11), pp. e70997. |
| Publication Type: | Journal Article; Review; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: John Wiley & Sons, Ltd Country of Publication: United States NLM ID: 101231978 Publication Model: Print Cited Medium: Internet ISSN: 1552-5279 (Electronic) Linking ISSN: 15525260 NLM ISO Abbreviation: Alzheimers Dement Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1552-5279 |
|---|---|
| DOI: | 10.1002/alz.70997 |
